These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23882695)

  • 21. A prospective pilot study of treatment outcomes for amblyopia associated with myopic anisometropia.
    Pang Y; Allison C; Frantz KA; Block S; Goodfellow GW
    Arch Ophthalmol; 2012 May; 130(5):579-84. PubMed ID: 22232365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Occlusion treatment for amblyopia. Age dependence and dose-response relationship].
    Fronius M
    Ophthalmologe; 2016 Apr; 113(4):296-303. PubMed ID: 27023273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occlusion treatment for amblyopia: assessing the performance of the electronic occlusion dose monitor.
    Fronius M; Chopovska Y; Nolden J; Loudon SE; Lüchtenberg M; Zubcov A; Pepler L
    Strabismus; 2006 Jun; 14(2):65-70. PubMed ID: 16760110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined optical and atropine penalization for the treatment of strabismic and anisometropic amblyopia.
    Kaye SB; Chen SI; Price G; Kaye LC; Noonan C; Tripathi A; Ashwin P; Cota N; Clark D; Butcher J
    J AAPOS; 2002 Oct; 6(5):289-93. PubMed ID: 12381987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized evaluation of spectacles plus alternate-day occlusion to treat amblyopia.
    Agervi P; Kugelberg U; Kugelberg M; Simonsson G; Fornander M; Zetterström C
    Ophthalmology; 2010 Feb; 117(2):381-7. PubMed ID: 20006908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of occlusion for strabismic amblyopia: can an optimal duration be identified?
    Cleary M
    Br J Ophthalmol; 2000 Jun; 84(6):572-8. PubMed ID: 10837378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-year follow-up of a randomized trial of spectacles plus alternate-day patching to treat strabismic amblyopia.
    Agervi P; Kugelberg U; Kugelberg M; Zetterström C
    Acta Ophthalmol; 2013 Nov; 91(7):678-84. PubMed ID: 22998746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial of increasing patching for amblyopia.
    ; Wallace DK; Lazar EL; Holmes JM; Repka MX; Cotter SA; Chen AM; Kraker RT; Beck RW; Clarke MP; Lorenzana IJ; Petersen DB; Roberts JT; Suh DW
    Ophthalmology; 2013 Nov; 120(11):2270-7. PubMed ID: 23755872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occlusion dose monitoring in amblyopia therapy: status, insights, and future directions.
    Stewart CE; Moseley MJ; Georgiou P; Fielder AR
    J AAPOS; 2017 Oct; 21(5):402-406. PubMed ID: 28890077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electronic monitoring of occlusion treatment for amblyopia in patients aged 7 to 16 years.
    Fronius M; Bachert I; Lüchtenberg M
    Graefes Arch Clin Exp Ophthalmol; 2009 Oct; 247(10):1401-8. PubMed ID: 19415317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An educational cartoon accelerates amblyopia therapy and improves compliance, especially among children of immigrants.
    Tjiam AM; Holtslag G; Vukovic E; Asjes-Tydeman WL; Loudon SE; Borsboom GJ; de Koning HJ; Simonsz HJ
    Ophthalmology; 2012 Nov; 119(11):2393-401. PubMed ID: 22920669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compliance and patching and atropine amblyopia treatments.
    Wang J
    Vision Res; 2015 Sep; 114():31-40. PubMed ID: 25743080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amblyopia treatment outcomes.
    Scott WE; Kutschke PJ; Keech RV; Pfeifer WL; Nichols B; Zhang L
    J AAPOS; 2005 Apr; 9(2):107-11. PubMed ID: 15838435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Strabismic amblyopia: a retrospective study on patients from a university hospital].
    Costa DS; Klein Rde C; Leite Cde A; Ginguerra MA; Polati M
    Arq Bras Oftalmol; 2006; 69(2):181-5. PubMed ID: 16699667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The treatment of amblyopia: current practice and emerging trends.
    Papageorgiou E; Asproudis I; Maconachie G; Tsironi EE; Gottlob I
    Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1061-1078. PubMed ID: 30706134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility of monitoring compliance with intermittent occlusion therapy glasses for amblyopia treatment.
    Wang J; Jin J; Malik A; Shoge R; Meiyeppen S; Pang Y; Yin K; Allen M; Scombordi B; Soni A; Neely DE; Januschowski K
    J AAPOS; 2019 Aug; 23(4):205.e1-205.e5. PubMed ID: 31271842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow-up of an amblyopia treatment study: change in visual acuity 15 years after occlusion therapy.
    Kadhum A; Simonsz-Tóth B; van Rosmalen J; Pijnenburg SJM; Janszen BM; Simonsz HJ; Loudon SE
    Acta Ophthalmol; 2021 Feb; 99(1):e36-e42. PubMed ID: 32657530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychosocial and clinical determinants of compliance with occlusion therapy for amblyopic children.
    Searle A; Norman P; Harrad R; Vedhara K
    Eye (Lond); 2002 Mar; 16(2):150-5. PubMed ID: 11988815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized pilot study of near activities versus non-near activities during patching therapy for amblyopia.
    Holmes JM; Edwards AR; Beck RW; Arnold RW; Johnson DA; Klimek DL; Kraker RT; Lee KA; Lyon DW; Nosel ER; Repka MX; Sala NA; Silbert DI; Tamkins S;
    J AAPOS; 2005 Apr; 9(2):129-36. PubMed ID: 15838439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized trial of near versus distance activities while patching for amblyopia in children aged 3 to less than 7 years.
    Pediatric Eye Disease Investigator Group
    Ophthalmology; 2008 Nov; 115(11):2071-8. PubMed ID: 18789533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.